Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Mulders

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|August 1, 1994
Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinomaH G van der Poel, P F Mulders, T W Aalders, et al.
European Urology|January 1, 1992
Value of biochemical markers in the management of disseminated prostatic cancerP F Mulders, P Fernandez del Moral, A G Theeuwes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study GroupP F Mulders, W J Hoekstra, R P Heybroek, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2008
No improvement in renal cell carcinoma survival: a population-based study in the NetherlandsK K H Aben, T K Luth, M L G Janssen-Heijnen, et al.
Cancer|November 1, 1993
Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneityH G van der Poel, P F Mulders, G O Oosterhof, et al.
The Netherlands Journal of Medicine|August 4, 2012
Kidney injury during VEGF inhibitor therapyE S G den Deurwaarder, I M E Desar, E J Steenbergen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groupsE W Steyerberg, H J Keizer, S D Fosså, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|August 1, 1994
Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinomaH G van der Poel, P F Mulders, T W Aalders, et al.
European Urology|January 1, 1992
Value of biochemical markers in the management of disseminated prostatic cancerP F Mulders, P Fernandez del Moral, A G Theeuwes, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study GroupP F Mulders, W J Hoekstra, R P Heybroek, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2008
No improvement in renal cell carcinoma survival: a population-based study in the NetherlandsK K H Aben, T K Luth, M L G Janssen-Heijnen, et al.
Cancer|November 1, 1993
Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneityH G van der Poel, P F Mulders, G O Oosterhof, et al.
The Netherlands Journal of Medicine|August 4, 2012
Kidney injury during VEGF inhibitor therapyE S G den Deurwaarder, I M E Desar, E J Steenbergen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groupsE W Steyerberg, H J Keizer, S D Fosså, et al.
Pageof 2